Kristian Cibulskis

Cancer Research · 2008–2020

A researcher in the Science corpus: 53 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Cancer Research — 367 citations into it

Whom Kristian Cibulskis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Gad Getz

Who trusts Kristian Cibulskis overall

1. Nicholas McGranahan
2. M. Lawrence
3. Niko Beerenwinkel
4. Scott L. Carter

Papers from Kristian Cibulskis's perspective

Ordered by how strongly the researchers Kristian Cibulskis trusts endorse each paper. Same corpus, a different order for every researcher.

1. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (Genome Biology)
2. RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES (Nature Genetics)
3. Malignant astrocytic glioma: genetics, biology, and paths to treatment. (Genes & Development)
4. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)
5. Predicting the functional impact of protein mutations: application to cancer genomics
6. Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing (Nature Biotechnology)
7. The genomic complexity of primary human prostate cancer (Nature)
8. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (Journal of the National Cancer Institute)
9. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer (Nature Chemical Biology)
10. BreakDancer: An algorithm for high resolution mapping of genomic structural variation (Nature Methods)

Their papers

• A framework for variation discovery and genotyping using next-generation DNA sequencing data (2011) — 11,249 citations
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. (2010) — 25,882 citations
• Somatic mutations affect key pathways in lung adenocarcinoma (2008) — 2,751 citations
• Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (2012) — 1,524 citations
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma (2011) — 2,541 citations
• The mutational constraint spectrum quantified from variation in 141,456 humans (2020) — 8,441 citations
• Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012) — 7,754 citations
• Mutational heterogeneity in cancer and the search for new cancer genes (2013) — 1,147 citations
• The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. (2014) — 705 citations
• Melanoma genome sequencing reveals frequent PREX2 mutations (2012) — 752 citations
• A Landscape of Driver Mutations in Melanoma (2012) — 2,528 citations
• Initial genome sequencing and analysis of multiple myeloma (2011) — 1,464 citations
• Evolution and impact of subclonal mutations in chronic lymphocytic leukemia (2013) — 1,402 citations
• A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries (2011) — 533 citations
• The genetic landscape of high-risk neuroblastoma (2013) — 1,115 citations
• Punctuated Evolution of Prostate Cancer Genomes (2013) — 1,269 citations
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing (2012) — 1,811 citations
• Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
• Comprehensive molecular profiling of lung adenocarcinoma (2014) — 5,176 citations